Drug Type Small molecule drug |
Synonyms Vesnarinone (JAN/USAN/INN), NDA 20390, OPC 8212 + [3] |
Target |
Mechanism PDE inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date (01 Jan 1990), |
Regulation- |
Molecular FormulaC22H25N3O4 |
InChIKeyZVNYJIZDIRKMBF-UHFFFAOYSA-N |
CAS Registry81840-15-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01690 | Vesnarinone |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Heart Failure | - | - | 01 Jan 1990 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
AIDS-related Kaposi Sarcoma | Phase 2 | US | 31 Aug 2001 | |
Neoplasms | Phase 2 | JP | - | |
HIV Infections | Phase 1 | JP | - |